Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | $4.90 | $2.00 | 68.95% | 58M | $7.4M | $1.33$21.00 |
| CVGI | Commercial Vehicle Group | $2.25 | $0.63 | 38.70% | 40.9M | $60M | $0.81$2.89 |
| SAGT | Sagtec Global | $2.45 | $0.62 | 33.88% | 1.2M | $23M | $1.10$6.24 |
| BODI | Beachbody | $10.88 | $2.55 | 30.55% | 158.5K | $59M | $3.38$12.66 |
| SERA | Sera Prognostics | $2.34 | $0.51 | 27.87% | 10.6K | $71M | $1.37$4.34 |
| HIMZ | Tidal Trust II - Defiance Daily Target 2x Long Hims ETF | $2.88 | $0.61 | 26.65% | 71.2M | - | $0.88$55.77 |
| OCGN | Ocugen | $2.24 | $0.47 | 26.55% | 740.3K | $580M | $0.52$2.31 |
| CYN | Cyngn | $2.02 | $0.42 | 26.25% | 1.4M | $13M | $1.33$41.54 |
| NBIG | Themes ETF Trust - Leverage Shares 2x Long Nbis Daily ETF | $8.74 | $1.81 | 26.07% | 2.6M | - | $4.51$19.45 |
| NBIL | GraniteShares ETF Trust - GraniteShares 2x Long Nbis Daily ETF | $12.36 | $2.53 | 25.74% | 3.6M | - | $6.37$38.58 |
| SXTP | 60 Degrees Pharmaceuticals | $2.36 | $0.48 | 25.53% | 14.2M | $2.0M | $1.36$17.68 |
| ADAG | Adagene | $3.67 | $0.74 | 25.26% | 79.3K | $138M | $1.30$4.53 |
| NVTS | Navitas Semiconductor | $10.60 | $1.92 | 22.06% | 952.3K | $2.0B | $1.52$17.79 |
| ORCX | Tidal Trust II - Defiance Daily Target 2x Long Orcl ETF | $11.29 | $1.84 | 19.47% | 25M | - | $8.00$60.53 |
| ORCU | Direxion Shares ETF Trust - Daily Orcl Bull 2x Etf | $12.15 | $1.97 | 19.31% | 2.8M | - | $8.58$27.62 |
| DCBO | Docebo | $22.26 | $3.56 | 19.04% | 14.6K | $538M | $16.07$33.70 |
| VELO | Velo3D | $14.65 | $2.26 | 18.20% | 3.9M | $305M | $1.43$23.84 |
| TURB | Turbo Energy | $4.10 | $0.63 | 18.10% | 1.7M | $38M | $0.57$20.45 |
| ACTG | Acacia Research | $4.90 | $0.75 | 18.07% | 35.9K | $400M | $2.70$5.03 |
| AHG | Akso Health Group | $2.10 | $0.32 | 17.98% | 4.7K | $1.5B | $0.83$2.33 |
| DOMO | Domo | $5.16 | $0.78 | 17.81% | 517.6K | $183M | $3.45$18.49 |
| AUNA | Auna | $5.61 | $0.81 | 16.88% | 1.5M | $355M | $4.46$7.87 |
| APYX | Apyx Medical | $4.01 | $0.56 | 16.23% | 14.7K | $142M | $0.76$4.50 |
| CRWG | Themes ETF Trust - Leverage Shares 2x Long Crwv Daily ETF | $2.74 | $0.38 | 16.10% | 29.6M | - | $2.09$19.63 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $14.67 | $2.03 | 16.06% | 161.4K | - | $11.23$41.60 |
| IXHL | Incannex Healthcare | $5.80 | $0.79 | 15.67% | 23.8K | $58M | $2.40$49.80 |
| NUAI | New Era Energy & Digital | $5.15 | $0.64 | 14.19% | 2.7M | $242M | $0.32$9.45 |
| UPB | Upstream Bio | $9.26 | $1.14 | 14.04% | 715.1K | $439M | $5.14$33.68 |
| HIMS | Hims & Hers Health | $26.75 | $3.28 | 13.97% | 2.2M | $5.3B | $13.74$70.43 |
| SSII | Ss Innovations International | $5.03 | $0.61 | 13.82% | 130.9K | $856M | $3.02$22.42 |
| ROMA | Roma Green Finance | $3.90 | $0.43 | 12.39% | 77.4K | $207M | $0.67$8.88 |
| RCAX | Tidal Trust II - Defiance Daily Target 2x Long Rcat ETF | $22.01 | $2.15 | 10.83% | 231.1K | - | $11.66$31.62 |
| METCZ | Ramaco Resources | $25.40 | -$0.05 | -0.20% | 46 | - | $23.18$26.00 |
Related Articles
Featured Article
Navitas Just Unveiled AI Data Center Technology Investors Need to See
Rick Orford|Mar 11, 2026
Navitas just revealed technology targeting one of the biggest hidden bottlenecks in the AI boom, and the implications for NVTS stock could surprise investors.
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
Geoffrey Seiler|Mar 9, 2026
Hims & Hers stock traded more than 40% higher after the deal was announced.
Hims & Hers Stock Pops 40%: Everything You Need to Know
Travis Hoium|Mar 9, 2026
Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk.
Down 70% Over the Past Year, Can Hims & Hers Health Stock Bounce Back?
Geoffrey Seiler|Feb 27, 2026
The company is looking toward international markets to boost its growth.
Should You Buy Navitas Semiconductor Stock Now?
John Ballard|Feb 24, 2026
The company's data center opportunity is enormous, but this is well reflected in the stock's valuation.
Where Will Navitas Semiconductor Be in 5 Years?
Micah Zimmerman|Feb 20, 2026
This stock is a high-risk, high-upside AI infrastructure play focused on making power delivery in chips more efficient.
Hims & Hers HUGE Acquisition News!
Travis Hoium|Feb 19, 2026
Hims & Hers is acquiring Eucalyptus and spreading its wings internationally.
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
Bram Berkowitz|Feb 9, 2026
Hims & Hers could face difficulty in the future in selling copycat GLP-1 drugs.
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
Travis Hoium|Feb 5, 2026
Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
Travis Hoium|Feb 4, 2026
Hims & Hers is moving beyond prescriptions to preventative testing.
